BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37919737)

  • 1. The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.
    Chauhan R; Varma G; Yafi E; Zuhairi MF
    BMC Public Health; 2023 Nov; 23(1):2142. PubMed ID: 37919737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M
    Front Immunol; 2022; 13():919408. PubMed ID: 35935993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines.
    Adjobimey T; Meyer J; Sollberg L; Bawolt M; Berens C; Kovačević P; Trudić A; Parcina M; Hoerauf A
    Front Immunol; 2022; 13():917905. PubMed ID: 35799790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
    Pourakbari B; Mirbeyk M; Mahmoudi S; Hosseinpour Sadeghi RH; Rezaei N; Ghasemi R; Esfandiari F; Mamishi S
    J Med Virol; 2022 Dec; 94(12):5669-5677. PubMed ID: 35883215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twitter sentiment analysis from Iran about COVID 19 vaccine.
    Bokaee Nezhad Z; Deihimi MA
    Diabetes Metab Syndr; 2022 Jan; 16(1):102367. PubMed ID: 34933273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
    Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
    J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines.
    Marcec R; Likic R
    Postgrad Med J; 2022 Jul; 98(1161):544-550. PubMed ID: 34373343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina.
    Eliçabe RJ; Distel MN; Jofré BL; Leporati M; Silva JE; Arias JL; Gorlino CV; Funes SC; Velazquez M; Vitale P; Davicino RC; Di Genaro MS
    Vaccine; 2023 Jan; 41(2):476-485. PubMed ID: 36481109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic Modeling.
    Huangfu L; Mo Y; Zhang P; Zeng DD; He S
    J Med Internet Res; 2022 Feb; 24(2):e31726. PubMed ID: 34783665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
    Gasmi A; Srinath S; Dadar M; Pivina L; Menzel A; Benahmed AG; Chirumbolo S; Bjørklund G
    Clin Immunol; 2022 Apr; 237():108958. PubMed ID: 35218966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
    Sughayer MA; Souan L; Abu Alhowr MM; Al Rimawi D; Siag M; Albadr S; Owdeh M; Al Atrash T
    Vaccine; 2022 May; 40(20):2841-2847. PubMed ID: 35397946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
    AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
    Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.
    Abdelhamid MHM; Almsellati IA; Annajar BB; Abdulhamid AH; Alemam H; Etikar M
    PLoS One; 2022; 17(11):e0276425. PubMed ID: 36327290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
    Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence-Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study.
    Hussain A; Tahir A; Hussain Z; Sheikh Z; Gogate M; Dashtipour K; Ali A; Sheikh A
    J Med Internet Res; 2021 Apr; 23(4):e26627. PubMed ID: 33724919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.